Investor Stock List
Ranked #3,275 of 8,699 institutional investors

Octagon Capital Advisors LP

New York, NY

$591M
US stock portfolio at live prices · today −$19.6M (−3.20%)
Live prices, last trade 11:29 AM ET
Value at quarter end (Q3 2026)
$740M
Change from Q2 2026
−$349.5M (−32.08%)
Positions
24 · 2 new, 3 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $10.6M of stock. $7.9M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
DNTH 23.9%DFTX 12.4%ABVX 11.6%COGT 10.7%TSHA 6.12%
StockSharesValue, live% of portfoliovs Q2 2026
DNTH Dianthus Therapeutics, Inc.1,686,667$141M23.9%Reduced −8%
DFTX Definium Therapeutics, Inc.2,511,000$73.1M12.4%Reduced −15%
ABVX ABIVAX Société Anonyme993,000$68.6M11.6%Unchanged
COGT Cogent Biosciences, Inc.2,350,000$63.3M10.7%Unchanged
TSHA Taysha Gene Therapies, Inc.9,693,244$36.2M6.12%Unchanged
OBX Obsidian Therapeutics, Inc.2,414,610$28.8M4.88%New
KYMR Kymera Therapeutics, Inc.205,000$23.7M4.01%Reduced −34%
AVBP ArriVent BioPharma, Inc.2,141,387$23.5M3.98%Added +9%
IRON Disc Medicine, Inc.270,000$20.2M3.42%Unchanged
MIRM Mirum Pharmaceuticals, Inc.169,450$16.6M2.81%Reduced −50%
XENE Xenon Pharmaceuticals Inc.420,000$15.7M2.65%Reduced −14%
TNGX Tango Therapeutics, Inc.630,000$14.1M2.39%New
AKTS Aktis Oncology, Inc.713,000$11.7M1.97%Reduced −26%
PALI Palisade Bio, Inc.10,276,317$9.6M1.62%Unchanged
ANL Adlai Nortye Group Ltd.934,716$8.1M1.36%Unchanged
BIOA BioAge Labs, Inc.1,300,000$5.8M0.99%Reduced −26%
DBVT DBV Technologies S.A.574,200$5.3M0.89%Unchanged
TRVI Trevi Therapeutics, Inc.315,000$4.2M0.71%Unchanged
GYRE Gyre Therapeutics, Inc.954,416$4.1M0.69%Unchanged
OCUL Ocular Therapeutix, Inc.599,900$3.4M0.58%Reduced −71%
DTIL Precision BioSciences, Inc.430,000$3.1M0.53%Reduced −68%
GOSS Gossamer Bio, Inc.96,875$1.1M0.19%Unchanged
UNCY Unicycive Therapeutics, Inc.275,000$965K0.16%Reduced −73%
FTH Faeth Therapeutics, Inc.100,000$865K0.15%Reduced −72%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
SMMT Summit Therapeutics Inc.1,250,000$12.8M
ALMS Alumis Inc.2,830,700$11.5M
CNTX Context Therapeutics Inc.3,050,000$519K